Viewing Study NCT07391657


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 1:34 AM
Study NCT ID: NCT07391657
Status: RECRUITING
Last Update Posted: 2026-03-12
First Post: 2026-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module